Close
Nordic 9Nordic 9

Zelluna Immunotherapy As (private company)

Norway zelluna.com
See something wrong or missing? Let us know
Offices:Oslo
Industry:BiotechHealth services
Business model:B2B

Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Zelluna Immunotherapy As

Name Criteria
United Kingdom Achilles Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
Norway APIM Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Sweden Aprea Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Germany Atai Life Sciences
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 4
United Kingdom Biofidelity
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
Denmark Biograil
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 4
Sweden BoneSupport
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Germany CatalYm
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
Sweden Cinclus Pharma
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
France Corlieve Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
Top